Utsunomiya, M., Dobashi, H., Odani, T., Saito, K., Yokogawa, N., Nagasaka, K., . . . Harigai, M. (2020). An open-label, randomized controlled trial of sulfamethoxazole–trimethoprim for Pneumocystis prophylaxis: Results of 52-week follow-up. Rheumatol Adv Pract.
Citación estilo ChicagoUtsunomiya, Masako, et al. "An Open-label, Randomized Controlled Trial of Sulfamethoxazole–trimethoprim for Pneumocystis Prophylaxis: Results of 52-week Follow-up." Rheumatol Adv Pract 2020.
Cita MLAUtsunomiya, Masako, et al. "An Open-label, Randomized Controlled Trial of Sulfamethoxazole–trimethoprim for Pneumocystis Prophylaxis: Results of 52-week Follow-up." Rheumatol Adv Pract 2020.
Precaución: Estas citas no son 100% exactas.